<ѻýҕl>First Detailed Look at COVID Vaccine Skin Reactionsѻýҕl> Mostly mild, self-limiting reactions and no serious adverse reactions May 05, 2021
<ѻýҕl>Rapid Improvement in Atopic Dermatitis With New JAK1 Inhibitorѻýҕl> Plus: First-in-class drug shows promise in AD, BTK inhibitor active in pemphigus May 03, 2021
<ѻýҕl>Topical JAK Inhibitor Shows Promise in Vitiligoѻýҕl> Half of patients had 90% improvement after 2 years of treatment Apr 30, 2021
<ѻýҕl>High Rate of Hyperhidrosis Relief With Topical Agentѻýҕl> Benefit for 86% of patients treated with sofpironium bromide Apr 29, 2021
<ѻýҕl>Rapid Improvement in Atopic Dermatitis With Topical JAK Inhibitorѻýҕl> Disease activity index improved as early as week 1 with delgocitinib cream Apr 27, 2021
<ѻýҕl>Significant Improvement in Hand Eczema With Pan-JAK Inhibitorѻýҕl> Disease activity indicators reduced, no safety signals with gusacitinib versus placebo Apr 26, 2021
<ѻýҕl>Big Win in Psoriasis for Dual IL-17A/17F Inhibitorѻýҕl> Significant differences in clearance with bimekizumab vs secukinumab at all time points Apr 23, 2021
<ѻýҕl>Op-Ed: Dermatology Needs Lower Costs and Better Careѻýҕl> A proposal for value-based care Apr 21, 2021
<ѻýҕl>Nivolumab Alone Prevails in Resected Melanomaѻýҕl> Adding ipilimumab in adjuvant setting failed to improve relapse-free survival Apr 11, 2021
<ѻýҕl>For Enthesitis in Psoriatic Arthritis, Target IL-23ѻýҕl> Targeted agent provides relief for many PsA patients Apr 08, 2021
<ѻýҕl>COVID Triggers Novel Infectious Skin Condition in Teenѻýҕl> Mild case led to unusual effects a week later Apr 07, 2021
<ѻýҕl>JAK Inhibitor Promising in Psoriatic Arthritisѻýҕl> Oral agent noninferior to adalimumab in joint symptoms Apr 01, 2021
<ѻýҕl>Using the Skin Microbiome to Control Atopic Dermatitisѻýҕl> Bacteria-based therapy shows promise in proof-of-concept trial Mar 01, 2021
<ѻýҕl>Young Hidradenitis Suppurativa Patients See Lags in Careѻýҕl> Diagnosis typically came years after disease onset; providers claim lack of knowledge on HS pain Feb 24, 2021
<ѻýҕl>Want Data on Recently Approved Actinic Keratosis Drug? Here You Goѻýҕl> Phase III trial now published in full for topical anti-proliferative treatment Feb 10, 2021
<ѻýҕl>Monoclonal Antibody Highly Effective in Phase III Psoriasis Trialѻýҕl> Beats ustekinumab, but main side effect was oral candidiasis Feb 05, 2021
<ѻýҕl>Brain Tumor Risk Upped With Synthetic Progestogenѻýҕl> Absolute risk still low, however, and product not currently approved in U.S. Feb 03, 2021
<ѻýҕl>High Potassium No Threat With Spironolactoneѻýҕl> Despite guidelines, many still monitoring K levels in young women with acne, researchers find Jan 27, 2021
<ѻýҕl>Masculinizing Hormone Therapy Tied to Acne in Transmenѻýҕl> Acne also linked with depression and anxiety; Accutane may be treatment option Jan 20, 2021
<ѻýҕl>Derm Symptoms Signal MIS-C in Kidsѻýҕl> Case series shows mucocutaneous findings in most children Dec 09, 2020
<ѻýҕl>Renewed Concerns About Finasteride and Mental Healthѻýҕl> Database study links popular alopecia treatment with increased risks of suicidality, depression Nov 27, 2020
<ѻýҕl>Eva Mendes Gets Mono-Threadingѻýҕl> A look at the movie star's recent beauty procedure Nov 24, 2020
<ѻýҕl>More Evidence for Ligelizumab in Chronic Hivesѻýҕl> Anti-IgE drug showed improved activity in omalizumab-treated patients with inadequate symptom control Nov 17, 2020
<ѻýҕl>Watch for Suicidality in Men on Propeciaѻýҕl> Analysis found high number of psychological-related reports Nov 11, 2020
<ѻýҕl>TYK2 Inhibition Promising in Psoriatic Arthritisѻýҕl> Phase II study found significant benefits for two doses of novel agent Nov 10, 2020
<ѻýҕl>Gut Bacteria for Psoriasis; Long-Term Hair Growth; COVID and STDsѻýҕl> Selected presentations from the European Academy of Dermatology and Venereology virtual conference Nov 05, 2020
<ѻýҕl>Nonsteroidal Topical, Nanodrug Active in Psoriasisѻýҕl> Selected presentations from the European Academy of Dermatology and Venereology meeting Nov 04, 2020
<ѻýҕl>Atopic Dermatitis: New Topical Agent, Durable Results With Oralsѻýҕl> Selected abstracts from the European Academy of Dermatology and Venereology Virtual Conference Nov 02, 2020
<ѻýҕl>First-Ever Positive Phase III Trial in Epidermolysis Bullosaѻýҕl> Faster wound healing with oleogel-S10, particularly in most common form of EB Nov 01, 2020
<ѻýҕl>Add Skin Conditions to COVID-19 Long-Hauler Effectsѻýҕl> Persistence beyond 60 days in some cases, especially with pernio/chilblains Oct 30, 2020
<ѻýҕl>Melanoma Survival Benefit Sustained at 5 Years With Adjuvant Comboѻýҕl> Dabrafenib plus trametinib cut relapse risk in half Sep 02, 2020
<ѻýҕl>Demographics Make a Difference in Common Skin Cancersѻýҕl> Study looks at epidemiology of basal versus squamous cell carcinomas Aug 26, 2020
<ѻýҕl>Calcineurin Blockers for Eczema: No Cancer Signal in Big Studyѻýҕl> "Clinicians can use this evidence to counsel and reassure patients" Aug 12, 2020
<ѻýҕl>New Insights Into Radiation-Induced Hair Lossѻýҕl> Total dose and fraction size matter, minoxidil may spur regrowth Aug 05, 2020
<ѻýҕl>Skin Rashes a Clue to COVID-19 Vascular Diseaseѻýҕl> Certain skin manifestations tied to coagulopathy in the sickest patients Aug 05, 2020
<ѻýҕl>Triplet OK'd as First-Line Therapy in Melanomaѻýҕl> Immunotherapy plus targeted combo nets FDA approval in BRAF-mutant population Jul 31, 2020
<ѻýҕl>DPP-4 Inhibitors Tied to Blistering Skin Conditionѻýҕl> Increased risk for bullous pemphigoid modified by patient age, race Jul 22, 2020
<ѻýҕl>Targeting IL-23 Relieves Multiple Symptoms in PsAѻýҕl> Both enthesitis and dactylitis improved with guselkumab treatment in psoriatic arthritis Jul 21, 2020
<ѻýҕl>COVID-19 May Manifest in the Mouth in Some Patientsѻýҕl> Pay attention to those with a rash, small case series from Spain advises Jul 15, 2020
<ѻýҕl>Psoriasis Cream Succeeds in Early Trialѻýҕl> PDE-4 inhibitor helped clear plaque psoriasis in 6 weeks Jul 15, 2020